NEW YORK (GenomeWeb) – Biocept said today that it has reached an agreement for the validation and potential adoption of its Target Selector liquid biopsy kits in Agiomix's lab in the United Arab Emirates lab.

Agiomix will test the kits to ensure comparability of results achieved in Biocept's San Diego CLIA-certified, CAP-accredited facility. Subject to that validation, Agiomix would then purchase the kits for use in its genomics test services, analyzing samples received from the Middle East, Africa, and Asia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.